Estelle Rolland

Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group

Jean‐Pierre Pignon, Hélène Tribodet, Giorgio V. Scagliotti et al. · Journal of Clinical Oncology · 2008 · 2.7K citations · Full text

Medicine, Oncology, Pharmacology +13

Pooled Analysis of the Effect of Age on Adjuvant Cisplatin-Based Chemotherapy for Completely Resected Non–Small-Cell Lung Cancer

Martin Früh, Estelle Rolland, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2008 · 196 citations

Medicine, Geriatric Medicine, Oncology +17

Operational response to malaria epidemics: are rapid diagnostic tests cost‐effective?

Estelle Rolland, Francesco Checchi, Loretxu Pinoges et al. · Tropical Medicine & International Health · 2006 · 70 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +17

A1-05: Concomitant radio-chemotherapy (RT-CT) versus sequential RT-CT in locally advanced non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomised clinical trials (RCTs)

Anne Aupérin, Estelle Rolland, Walter J. Curran et al. · Journal of Thoracic Oncology · 2007 · 61 citations · Full text

Medicine, Oncology, Radiation Oncology +11

Cross-Validation Study for Epidermal Growth Factor Receptor and KRAS Mutation Detection in 74 Blinded Non-small Cell Lung Carcinoma Samples: A Total of 5550 Exons Sequenced by 15 Molecular French Laboratories (Evaluation of the EGFR Mutation Status for the Administration of EGFR-TKIs in Non-Small Cell Lung Carcinoma [ERMETIC] Project—Part 1)

Michèle Beau‐Faller, Armelle Degeorges, Estelle Rolland et al. · Journal of Thoracic Oncology · 2011 · 54 citations · Full text

Medicine, Molecular Genetics, Oncology +17